Pay in 4 interest-free payments of $5.13 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
In mouse models of Alzheimer's disease, systemic administration of GHK-Cu for 12 weeks results in 30% improvement in cognitive function tests and 25% reduction in brain amyloid plaque burden compared to vehicle-treated controls
The purchase and the doctor interview was really easy
For researchers conducting GHK-Cu copper peptide research, this evidence base is a primary selection criterion in any Matrixyl vs GHK-Cu decision
Combined antioxidant, anti-inflammaging and mesenchymal stem cell treatment: a possible therapeutic direction in elderly patients with chronic obstructive pulmonary disease
Elsevier, 187212
US$ 21.23
US$ 27.32
US$ 20.02
US$ 25.42
US$ 29.60
US$ 26.28
US$ 24.04
